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1682-606X/Copyright ª 2015, TaiwanSummary Phyllodes tumors (PTs) are an infrequent breast tumor presentation. An invasive
carcinoma arising in a borderline PT is extremely rare. A 58-year-old female presented with
a mass over the left breast, which she had had for >1 year, with rapid growth in the past 3
months. The patient underwent wide excision under the assumption that the mass was a PT.
Invasive ductal carcinoma and ductal carcinoma in situ arising in a borderline PT were inci-
dentally found. Because the surgical margin was <1 mm, the patient underwent a partial
mastectomy to provide a safe margin and a sentinel node biopsy. The pathology of the sec-
ond excision revealed neither a residual tumor nor lymph node metastasis. The pathologic
stage was T2N0M0. This was an extremely rare case of invasive ductal carcinoma arising
in a borderline PT, and the clinical course, image, and histological findings are discussed
in this paper.
Copyright ª 2015, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
The term phyllodes is derived from the Greek word phyllon
(meaning leaf) and refers to a rapidly growing, large breastave no conflicts of interest.
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Surgical Association. Published bytumor that can cause breast distortion and pressure ne-
crosis of the overlying skin. The tumor appears leaflike in
cross section and originates from the periductal stromal
cells of the breast. Such tumors account for <1% of all
breast neoplasms. Invasive carcinoma arising in malignant
phyllodes tumors (PTs) has been reported in previous
studies.1,2 In this paper, we present a rare case with the
initial impression of PT. The final diagnosis was invasive
ductal carcinoma and ductal carcinoma in situ arising in a
borderline PT.Elsevier Taiwan LLC. All rights reserved.
Figure 2 Ultrasound examination of the left breast revealed
a well-defined, lobulated, and hypoechoic mass measuring
6 cm  4 cm.
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A 58-year-old female patient had a palpable mass over the
left breast for >1 year, but she did not undergo any ex-
amination. She came to our hospital because the tumor had
grown rapidly in the past 3 months. She has no family his-
tory of breast cancer. A physical examination revealed a
well-defined, freely movable, and elastic mass 7 cm  5 cm
in size, located in the 3 o’clock direction and 3 cm from the
left breast nipple. There were no palpable lymph nodes
over the supraclavicle or axillary region.
A mammography showed a high-density mass approxi-
mately 6.6 cm in length with an obscured margin over the
upper outer quadrant of the left breast (Fig. 1). An ultra-
sonography revealed a well-defined, lobulated, and hypo-
echoic mass, approximately 6 cm  4 cm in size, in the left
breast without enlarged lymph nodes over the bilateral
axillary region (Fig. 2).
Tumor markers, such as CEA and CA15-3, were within
normal limits. Fine-needle aspiration cytology revealed
clusters of benign, proliferative ductal epithelia and bipolar
cells but no malignant cells. Under the impression that the
patient had a PT of the left breast, a wide excision was
performed, and a well-defined, soft-to-firm, rubber-like
nodule 6 cm  4 cm  3 cm in size was found.
A histological study revealed a well-circumscribed tumor
with a focal infiltrative border composed predominantly of
fibroadenoma-like areas focally arranged in a leaflike
architectural pattern created by extensive branching of the
epithelial component. In addition, stromal hypercellularity
with spindle-cell nuclei was found (Fig. 3). The mitotic
activity was increased with moderate cellular pleomor-
phism. The ductal epithelia exhibited a variable degree of
hyperplasia. Several ducts were arranged as invasive
islands, often angulated, in which well-defined spaces were
formed by arches of cells (a sieve-like or cribriformFigure 1 Mediolateral oblique mammography showed a high-
density mass with an obscured margin over the upper outer
quadrant of the left breast.pattern). Part of the tumor was composed of a single layer
of epithelial cells enclosing a clear lumen. These tubules
were generally ovate or rounded. The tumor cells were
small and regular with little evidence of nuclear pleomor-
phism. Mitoses were clearly observed in several areas. In
addition, a prominent reactive-appearing fibroblastic
stroma was present.
The formal pathology report stated that the tumor
consisted of Grade 1 invasive ductal carcinoma and cribri-
form type, intermediate grade, borderline in situ ductal
carcinoma arising in a PT, with the largest invasive carci-
noma being 2.5 cm  1 cm in size. The carcinoma compo-
nent stained 99% for estrogen receptor, 90% for
progesterone receptor, and 1þ for HER2/neu (Fig. 4). The
absence of basal myoepithelial lining was confirmed by
negativity for p63. The surgical margin was <1 mm from the
PT.
Two weeks later, the patient underwent a partial mas-
tectomy to provide a safe margin and a sentinel node bi-
opsy. The pathology of re-excision showed neither a
residual tumor nor lymph node metastasis. The pathologic
stage was T2N0M0. The patient was discharged and had an
uneventful postoperative course.Figure 3 Leaflike structures of the epithelial component
with stromal hypercellularity (40).
Figure 4 The carcinoma component stained (A) 99% for the estrogen receptor (immunohistochemistry, 200); (B) 1þ for HER2/
neu (immunohistochemistry, 200).
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PTs are fibroepithelial tumors composed of epithelial and
cellular stromal components. They were first described by
Johannes Mueller in 1838.3 Histologically, they may be
considered benign, borderline, or malignant, depending on
certain features including degree of stromal cellular atypia,
type of tumor margin (infiltrative vs. circumscribed),
mitotic activity, and the presence or absence of stromal
overgrowth.4,5
PTs are typically benign and can be cured through wide
excision with histologic margins negative for malignant
cells.6 A histologic margin of at least 1 cm has been re-
ported in previous studies.4,7 The stromal component may
undergo malignant transformation; hence, the misleading
traditional term cystosarcoma phyllodes. However, it is
rare for epithelia to undergo such a change, which usually
occurs in cases of malignant PTs.1,2
The patient in this study exhibited a rapidly enlarging
left breast mass corresponding to the clinical course of PTs.
The mammography revealed a high-density mass with an
obscured margin and the sonography revealed a well-
defined, lobulated, and hypoechoic mass, which consti-
tute typical findings of a PT.8 However, PTs are difficult to
distinguish from other tumors on the basis of clinical history
and radiologic features.9
Treatment of these rare cases should be tailored to
address the PTs and invasive carcinomas individually. PTs
are treated through wide excision, and invasive carcinomas
should be treated using a method including sampling/
dissection of the axillary lymph nodes as well as adjuvant
therapy based on the pathologic stage, tumor estrogen
receptor, progesterone receptor, and HER2/neu status.
Lenhard et al10 reported the local recurrence of borderline
PT to be 20%. The prognosis of invasive ductal carcinoma is
based on the classification of conventional histology and
immunohistochemistry. Currently, there is little consensus
on the prognosis of this rare disease.In conclusion, surgical resection of the tumor with a safe
margin and thorough sampling of the tumor are necessary
to fully assess its biologic characteristics and detect areas
of stromal overgrowth that suggest malignant behavior. In
addition, it is crucial to be aware that rare cases of carci-
noma may arise within a PT.References
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